Efficacy and Safety of Inotersen in Familial Amyloid Polyneuropathy

Clinical trial NCT01737398 · COMPLETED

Trial details

NCT number: NCT01737398
Sponsor: Ionis Pharmaceuticals, Inc.
Status: COMPLETED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

FAP Familial Amyloid Polyneuropathy TTR Transthyretin Amyloidosis

Start date: 2013-03-15
Primary completion: 2017-03-03
Enrollment: 173

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.